{"id":1021580,"date":"2026-11-16T16:19:56","date_gmt":"2026-11-16T21:19:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/"},"modified":"2026-11-16T16:19:56","modified_gmt":"2026-11-16T21:19:56","slug":"inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/","title":{"rendered":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MIAMI, Nov.  16, 2026  (GLOBE NEWSWIRE) &#8212; InspireMD, Inc. (Nasdaq: NSPR) (\u201cInspireMD\u201d or the \u201cCompany\u201d), developer of the CGuard\u00ae Prime carotid stent system for the prevention of stroke, today announced that multiple talks featuring CGuard\u00ae and the CGuard Prime carotid stent platform are scheduled to take place at VEITHsymposium 2026, being held November 17\u201321, 2026, in New York City.<\/p>\n<p>The talks will highlight primary endpoint results from the C-GUARDIANS II trial and the status of the ongoing C-GUARDIANS III trial of the SwicthGuard neuroprotection system (\u201cNPS\u201d) and three-year follow-up data involving 621 asymptomatic patients from the CGUARDIANS trial, among other sessions on the benefits of the CGuard Stent.<\/p>\n<p>Details of the talks are as follows:<\/p>\n<p>\n        <strong>Title: Progress And Updated Clinical Trials with the CGuard And CGuard Prime MicroMesh Covered Stents (From InspireMD) Including 3-Year Follow-Up Data On 621 Asymptomatic Patients: Are These MCSTs Making a Positive Difference Without Downsides: Should They Become First Line Therapy for All CAS And TCAR Procedures <\/strong><br \/>\n        <br \/>Presenter: Piotr Musialek, MD, DPhil, Professor of Cardiovascular Medicine at Jagiellonian University Medical College and St. John Paul II Hospital, Krakow, Poland <br \/>Date: Friday, November 20, 2026 <br \/>Time: 8:06\u20138:11 a.m. ET <br \/>Session: 86<\/p>\n<p>\n        <strong>Title: Primary Endpoint Results of the InspireMD C-GUARDIANS II MICROMESH STENT TCAR Trial, And Update On C-GUARDIANS III Trial Status: Will This System Optimize Carotid Stenting <\/strong><br \/>\n        <br \/>Presenter: Patrick J. Geraghty, MD, Professor of Surgery and Radiology at Washington University School of Medicine in St. Louis, Missouri<br \/>Date: Friday, November 20, 2026<br \/>Time: 8:12\u20138:17 a.m. ET <br \/>Session: 86<\/p>\n<p>For additional information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jUzXNJ2Z5StXWmDESJ82-SeWgenTxdvgUAzXWZUiPuugbDFcNWbzueg3-Kgd5u8fM3lpm-Ih7JeC07APS52p4xfa3Oyp29UGw1QlDk_l0Ko=\" rel=\"nofollow\" target=\"_blank\">www.veithsymposium.org<\/a>.<\/p>\n<p>\n        <strong>About VEITHsymposium<\/strong><br \/>\n        <br \/>VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The five-day event features rapid-fire presentations from world-renowned vascular specialists, with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.<\/p>\n<p>\n        <strong>About InspireMD, Inc.<br \/><\/strong>InspireMD seeks to utilize its proprietary MicroNet\u2122 mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD\u2019s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company\u2019s website. For more information, please visit www.inspiremd.com.<\/p>\n<p>\n        <strong>Investor Contacts:<br \/><\/strong>Jeff Warren<br \/>LifeSci Advisors <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-Xo9dGm1Ps6GwVOw5Rqol0sgoAvdNDL1MBbj9gBSXcUXF2V5BQE6kj76F7PmqI5uw00lfGBnARfWox2wLh91_ihtptli0HpZUGUMcqE_ocyJg_TZQ-rg7YkSpykIcyQJ\" rel=\"nofollow\" target=\"_blank\">jwarren@lifesciadvisors.com<\/a><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rROOiYJxYkZThihb0OHyCXldacsosL4aDY9rKAF0mh2jMP9SfsF1uXXTkHwDGntsH4B5TykD7RyKHbjF7vikev9FwiH1emOAWOIX5bT4Ni7V_G44UH_OcY-Z2rTEHSB7xii-doTeHqQrqw0NYnjROQ==\" rel=\"nofollow\" target=\"_blank\">investor-relations@inspiremd.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YzA3NDg2ZjgtNGNlOS00Zjk1LThhMDUtMDFlNzUxNjJmMDBmLTExOTc4MTYtMjAyNi0xMS0xNi1lbg==\/tiny\/InspireMD-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) &#8212; InspireMD, Inc. (Nasdaq: NSPR) (\u201cInspireMD\u201d or the \u201cCompany\u201d), developer of the CGuard\u00ae Prime carotid stent system for the prevention of stroke, today announced that multiple talks featuring CGuard\u00ae and the CGuard Prime carotid stent platform are scheduled to take place at VEITHsymposium 2026, being held November 17\u201321, 2026, in New York City. The talks will highlight primary endpoint results from the C-GUARDIANS II trial and the status of the ongoing C-GUARDIANS III trial of the SwicthGuard neuroprotection system (\u201cNPS\u201d) and three-year follow-up data involving 621 asymptomatic patients from the CGUARDIANS trial, among other sessions on the benefits of the CGuard Stent. Details of the talks are as follows: Title: Progress And Updated Clinical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1021580","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) &#8212; InspireMD, Inc. (Nasdaq: NSPR) (\u201cInspireMD\u201d or the \u201cCompany\u201d), developer of the CGuard\u00ae Prime carotid stent system for the prevention of stroke, today announced that multiple talks featuring CGuard\u00ae and the CGuard Prime carotid stent platform are scheduled to take place at VEITHsymposium 2026, being held November 17\u201321, 2026, in New York City. The talks will highlight primary endpoint results from the C-GUARDIANS II trial and the status of the ongoing C-GUARDIANS III trial of the SwicthGuard neuroprotection system (\u201cNPS\u201d) and three-year follow-up data involving 621 asymptomatic patients from the CGUARDIANS trial, among other sessions on the benefits of the CGuard Stent. Details of the talks are as follows: Title: Progress And Updated Clinical &hellip; Continue reading &quot;InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-16T21:19:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026\",\"datePublished\":\"2026-11-16T21:19:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/\"},\"wordCount\":398,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/\",\"name\":\"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\",\"datePublished\":\"2026-11-16T21:19:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/","og_locale":"en_US","og_type":"article","og_title":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk","og_description":"MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) &#8212; InspireMD, Inc. (Nasdaq: NSPR) (\u201cInspireMD\u201d or the \u201cCompany\u201d), developer of the CGuard\u00ae Prime carotid stent system for the prevention of stroke, today announced that multiple talks featuring CGuard\u00ae and the CGuard Prime carotid stent platform are scheduled to take place at VEITHsymposium 2026, being held November 17\u201321, 2026, in New York City. The talks will highlight primary endpoint results from the C-GUARDIANS II trial and the status of the ongoing C-GUARDIANS III trial of the SwicthGuard neuroprotection system (\u201cNPS\u201d) and three-year follow-up data involving 621 asymptomatic patients from the CGUARDIANS trial, among other sessions on the benefits of the CGuard Stent. Details of the talks are as follows: Title: Progress And Updated Clinical &hellip; Continue reading \"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-16T21:19:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026","datePublished":"2026-11-16T21:19:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/"},"wordCount":398,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/","name":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==","datePublished":"2026-11-16T21:19:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTMwMzk1NiM0MDI1NjQ4NjUjMjE4NjI2Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/inspiremd-announces-talks-featuring-cguard-and-cguard-prime-at-veithsymposium-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"InspireMD Announces Talks Featuring CGuard and CGuard Prime at VEITHsymposium 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021580","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1021580"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021580\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1021580"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1021580"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1021580"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}